Anti-CYP2S1 antibody
| Name | Anti-CYP2S1 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab69650 |
| Prices | $370.00 |
| Sizes | 100 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA WB IHC-P ICC/IF ICC/IF |
| Species Reactivities | Human, Mouse |
| Antigen | Synthetic peptide derived from an internal sequence of human CYP2S1 |
| Description | Rabbit Polyclonal |
| Gene | CYP2S1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
ab69650 at 1/500 dilution staining CYP2S1 in A549 cells by Immunofluorescence, in the absence or presence of the immunising peptide
ab69650 at 1/50 dilution staining CYP2S1 in human lung carcinoma by Immunohistochemistry, Paraffin-embedded tissue, in the absence or presence of the immunising peptide.
All lanes : Anti-CYP2S1 antibody (ab69650) at 1/500 dilutionLane 1 : HUVEC cell extractLane 2 : COLO cell extractLane 3 : COLO cell extract with immunising peptide at 10 µgLysates/proteins at 30 µg per lane.
Product References
Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits - Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits
Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, Mendell JT, Maitra A. Mol Cancer Ther. 2011 Aug;10(8):1470-80.
CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610, - CYP2S1 and CYP2W1 mediate 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW-610,
Tan BS, Tiong KH, Muruhadas A, Randhawa N, Choo HL, Bradshaw TD, Stevens MF, Leong CO. Mol Cancer Ther. 2011 Oct;10(10):1982-92.